Cargando…

Diversity of Heparan Sulfate and HSV Entry: Basic Understanding and Treatment Strategies

A modified form of heparan sulfate (HS) known as 3-O-sulfated heparan sulfate (3-OS HS) generates fusion receptor for herpes simplex virus (HSV) entry and spread. Primary cultures of corneal fibroblasts derived from human eye donors have shown the clinical significance of this receptor during HSV co...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiwari, Vaibhav, Tarbutton, Morgan S., Shukla, Deepak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272628/
https://www.ncbi.nlm.nih.gov/pubmed/25665065
http://dx.doi.org/10.3390/molecules20022707
_version_ 1783377200932716544
author Tiwari, Vaibhav
Tarbutton, Morgan S.
Shukla, Deepak
author_facet Tiwari, Vaibhav
Tarbutton, Morgan S.
Shukla, Deepak
author_sort Tiwari, Vaibhav
collection PubMed
description A modified form of heparan sulfate (HS) known as 3-O-sulfated heparan sulfate (3-OS HS) generates fusion receptor for herpes simplex virus (HSV) entry and spread. Primary cultures of corneal fibroblasts derived from human eye donors have shown the clinical significance of this receptor during HSV corneal infection. 3-OS HS- is a product of a rare enzymatic modification at C3 position of glucosamine residue which is catalyzed by 3-O-sulfotransferases (3-OSTs) enzymes. From humans to zebrafish, the 3-OST enzymes are highly conserved and widely expressed in cells and tissues. There are multiple forms of 3-OSTs each producing unique subset of sulfated HS making it chemically diverse and heterogeneous. HSV infection of cells or zebrafish can be used as a unique tool to understand the structural-functional activities of HS and 3-OS HS and likewise, the infection can be used as a functional assay to screen phage display libraries for identifying HS and 3-OS HS binding peptides or small molecule inhibitors. Using this approach over 200 unique 12-mer HS and 3-OS HS recognizing peptides were isolated and characterized against HSV corneal infection where 3-OS HS is known to be a key receptor. In this review we discuss emerging role of 3-OS HS based therapeutic strategies in preventing viral infection and tissue damage.
format Online
Article
Text
id pubmed-6272628
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62726282018-12-13 Diversity of Heparan Sulfate and HSV Entry: Basic Understanding and Treatment Strategies Tiwari, Vaibhav Tarbutton, Morgan S. Shukla, Deepak Molecules Review A modified form of heparan sulfate (HS) known as 3-O-sulfated heparan sulfate (3-OS HS) generates fusion receptor for herpes simplex virus (HSV) entry and spread. Primary cultures of corneal fibroblasts derived from human eye donors have shown the clinical significance of this receptor during HSV corneal infection. 3-OS HS- is a product of a rare enzymatic modification at C3 position of glucosamine residue which is catalyzed by 3-O-sulfotransferases (3-OSTs) enzymes. From humans to zebrafish, the 3-OST enzymes are highly conserved and widely expressed in cells and tissues. There are multiple forms of 3-OSTs each producing unique subset of sulfated HS making it chemically diverse and heterogeneous. HSV infection of cells or zebrafish can be used as a unique tool to understand the structural-functional activities of HS and 3-OS HS and likewise, the infection can be used as a functional assay to screen phage display libraries for identifying HS and 3-OS HS binding peptides or small molecule inhibitors. Using this approach over 200 unique 12-mer HS and 3-OS HS recognizing peptides were isolated and characterized against HSV corneal infection where 3-OS HS is known to be a key receptor. In this review we discuss emerging role of 3-OS HS based therapeutic strategies in preventing viral infection and tissue damage. MDPI 2015-02-05 /pmc/articles/PMC6272628/ /pubmed/25665065 http://dx.doi.org/10.3390/molecules20022707 Text en © 2015 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tiwari, Vaibhav
Tarbutton, Morgan S.
Shukla, Deepak
Diversity of Heparan Sulfate and HSV Entry: Basic Understanding and Treatment Strategies
title Diversity of Heparan Sulfate and HSV Entry: Basic Understanding and Treatment Strategies
title_full Diversity of Heparan Sulfate and HSV Entry: Basic Understanding and Treatment Strategies
title_fullStr Diversity of Heparan Sulfate and HSV Entry: Basic Understanding and Treatment Strategies
title_full_unstemmed Diversity of Heparan Sulfate and HSV Entry: Basic Understanding and Treatment Strategies
title_short Diversity of Heparan Sulfate and HSV Entry: Basic Understanding and Treatment Strategies
title_sort diversity of heparan sulfate and hsv entry: basic understanding and treatment strategies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272628/
https://www.ncbi.nlm.nih.gov/pubmed/25665065
http://dx.doi.org/10.3390/molecules20022707
work_keys_str_mv AT tiwarivaibhav diversityofheparansulfateandhsventrybasicunderstandingandtreatmentstrategies
AT tarbuttonmorgans diversityofheparansulfateandhsventrybasicunderstandingandtreatmentstrategies
AT shukladeepak diversityofheparansulfateandhsventrybasicunderstandingandtreatmentstrategies